Elizabeth L Stegemöller1, David P Allen2, Tanya Simuni3, Colum D MacKinnon4. 1. Department of Physical Therapy and Human Movement Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA; Department of Kinesiology, Iowa State University, Ames, IA 50011, USA. Electronic address: esteg@iastate.edu. 2. Department of Physical Therapy and Human Movement Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. Electronic address: dp.allen62@gmail.com. 3. Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. Electronic address: t-simuni@northwestern.edu. 4. Department of Physical Therapy and Human Movement Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA; Department of Neurology, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: cmakinn@umn.edu.
Abstract
OBJECTIVE: Impaired repetitive movement in persons with Parkinson's disease (PD) is associated with reduced amplitude, paradoxical hastening and hesitations or arrest at higher movement rates. This study examined the effects of movement rate and medication on movement-related cortical oscillations in persons with PD. METHODS: Nine participants with PD were studied off and on medication and compared to nine control participants. Participants performed index finger movements cued by tones from 1 to 3 Hz. Movement-related oscillations were derived from electroencephalographic recordings over the region of the contralateral sensorimotor cortex (S1/M1) during rest, listening, or synchronized movement. RESULTS: At rest, spectral power recorded over the region of the contralateral S1/M1 was increased in the alpha band and decreased in the beta band in participants with PD relative to controls. During movement, the level of alpha and beta band power relative to baseline was significantly reduced in the PD group, off and on medication, compared to controls. Reduced movement amplitude and hastening at movement rates near 2 Hz was associated with abnormally suppressed and persistent desynchronization of oscillations in alpha and beta bands. CONCLUSION: Motor cortical oscillations in the alpha and beta bands are abnormally suppressed in PD, particularly during higher rate movements. SIGNIFICANCE: These findings contribute to the understanding of mechanisms underlying impaired repetitive movement in PD.
OBJECTIVE:Impaired repetitive movement in persons with Parkinson's disease (PD) is associated with reduced amplitude, paradoxical hastening and hesitations or arrest at higher movement rates. This study examined the effects of movement rate and medication on movement-related cortical oscillations in persons with PD. METHODS: Nine participants with PD were studied off and on medication and compared to nine control participants. Participants performed index finger movements cued by tones from 1 to 3 Hz. Movement-related oscillations were derived from electroencephalographic recordings over the region of the contralateral sensorimotor cortex (S1/M1) during rest, listening, or synchronized movement. RESULTS: At rest, spectral power recorded over the region of the contralateral S1/M1 was increased in the alpha band and decreased in the beta band in participants with PD relative to controls. During movement, the level of alpha and beta band power relative to baseline was significantly reduced in the PD group, off and on medication, compared to controls. Reduced movement amplitude and hastening at movement rates near 2 Hz was associated with abnormally suppressed and persistent desynchronization of oscillations in alpha and beta bands. CONCLUSION: Motor cortical oscillations in the alpha and beta bands are abnormally suppressed in PD, particularly during higher rate movements. SIGNIFICANCE: These findings contribute to the understanding of mechanisms underlying impaired repetitive movement in PD.
Authors: Nicolas Mallet; Alek Pogosyan; Andrew Sharott; Jozsef Csicsvari; J Paul Bolam; Peter Brown; Peter J Magill Journal: J Neurosci Date: 2008-04-30 Impact factor: 6.167
Authors: John G Nutt; Bastiaan R Bloem; Nir Giladi; Mark Hallett; Fay B Horak; Alice Nieuwboer Journal: Lancet Neurol Date: 2011-08 Impact factor: 44.182
Authors: Alexandros G Androulidakis; Christof Brücke; Florian Kempf; Andreas Kupsch; Tipu Aziz; Keyoumars Ashkan; Andrea A Kühn; Peter Brown Journal: Eur J Neurosci Date: 2008-02-29 Impact factor: 3.386
Authors: Raoul Huys; Breanna E Studenka; Nicole L Rheaume; Howard N Zelaznik; Viktor K Jirsa Journal: PLoS Comput Biol Date: 2008-04-25 Impact factor: 4.475
Authors: Ying Yu; David Escobar Sanabria; Jing Wang; Claudia M Hendrix; Jianyu Zhang; Shane D Nebeck; Alexia M Amundson; Zachary B Busby; Devyn L Bauer; Matthew D Johnson; Luke A Johnson; Jerrold L Vitek Journal: J Neurosci Date: 2021-01-22 Impact factor: 6.167
Authors: Jae Woo Chung; Roxana G Burciu; Edward Ofori; Stephen A Coombes; Evangelos A Christou; Michael S Okun; Christopher W Hess; David E Vaillancourt Journal: Neuroimage Clin Date: 2018-05-18 Impact factor: 4.881